These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25848402)

  • 1. Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.
    Rizvi M; Ahmad J; Khan F; Shukla I; Malik A; Sami H
    Australas Med J; 2015; 8(1):1-6. PubMed ID: 25848402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of combination therapy by time kill curve analysis and chequerboard assay for treatment of multi-drug resistant Pseudomonas aeruginosa isolates.
    Rizvi M; Ahmed J; Khan F; Shukla I; Malik A
    J Glob Antimicrob Resist; 2013 Jun; 1(2):103-108. PubMed ID: 27873576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
    Burgess DS; Nathisuwan S
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):35-41. PubMed ID: 12376029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESBL and MBL in Cefepime Resistant Pseudomonas aeruginosa: An Update from a Rural Area in Northern India.
    Kotwal A; Biswas D; Kakati B; Singh M
    J Clin Diagn Res; 2016 Apr; 10(4):DC09-11. PubMed ID: 27190800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
    Dawis MA; Isenberg HD; France KA; Jenkins SG
    J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
    Casellas JM; Tomé G; Bantar C; Bertolini P; Blázquez N; Borda N; Couto E; Cudmani N; Guerrera J; Juárez MJ; López T; Littvik A; Méndez E; Notario R; Ponce G; Quinteros M; Salamone F; Sparo M; Sutich E; Vaylet S; Wolff L
    Diagn Microbiol Infect Dis; 2003 Nov; 47(3):527-37. PubMed ID: 14596972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial resistance monitoring of gram-negative bacilli isolated from 15 teaching hospitals in 2014 in China].
    Wang Q; Wang H; Yu Y; Xu X; Sun Z; Lu J; Yang B; Zhang L; Hu Z; Feng X; Xu Y; Ni Y; Mei Y; Liao K; Ji P; Chu Y
    Zhonghua Nei Ke Za Zhi; 2015 Oct; 54(10):837-45. PubMed ID: 26675021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N; Rao P; Arora J; Dogra A
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The annual changes in antimicrobial susceptibility test results of Pseudomonas aeruginosa isolates from the Kinki district].
    Fukuda S; Komatsu M; Nakamura T; Jikimoto T; Nishio H; Yamasaki K; Satoh K; Toda H; Orita T; Sueyoshi N; Kita M; Nishi I; Akagi M; Higuchi T; Kofuku T; Nakai I; Ono T; Kida K; Ohama M; Watari H; Shimura S; Niki M; Kuchibiro T; Wada Y
    Jpn J Antibiot; 2016 Apr; 69(2):101-10. PubMed ID: 27544978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa.
    Sivagurunathan N; Krishnan S; Rao JV; Nagappa AN; Subrahmanyam VM; Vanathi BM
    J Med Microbiol; 2008 Dec; 57(Pt 12):1514-1517. PubMed ID: 19018022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Burgess DS; Hastings RW
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):37-41. PubMed ID: 11025182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.
    Chachanidze V; Curbelo-Irizarry A; Ashcraft D; Pankey G
    Interdiscip Perspect Infect Dis; 2009; 2009():984934. PubMed ID: 19911066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
    Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
    J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
    Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
    Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
    Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of NDM - 1 in the Clinical Isolates of Pseudomonas aeruginosa in India.
    Khajuria A; Praharaj AK; Kumar M; Grover N
    J Clin Diagn Res; 2013 Jul; 7(7):1328-31. PubMed ID: 23998058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.